Toxicology International (Formerly Indian Journal of Toxicology)

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Effects of Metformin on High-Fat Diet-Induced Hyperlipidemic Rats


Affiliations
1 Laboratory of Pharmacology and Toxicology, Universitas Indonesia, Kampus UI Depok, 16424, Indonesia
     

   Subscribe/Renew Journal


Metformin as insulin sensitizer is now often associated with a significant decrease in plasma triglycerides, plasma total cholesterol, LDL cholesterol, and a significant increase in plasma HDL cholesterol without causing hypoglycemia. Current research aim are to determine the effects of metformin on high-fat diet-induced hyperlipidemic rats. To this end, a total of 30 Sprague-Dawley rats were divided into six groups (N = 5). Normal control was not treated, the negative group was given 0.5% CMC, the positive group used simvastatin dose of 1.8 mg/kg BW/day orally and three variation dose groups of metformin were given at a dose of 225; 450; and 900 mg/kg BW rat/day orally. Induction was carried out for 28 days and continued for 14 days treated with an administration orally. Lipid profile was measured by the colorimetric enzymatic method. As a result, all doses of metformin significantly decreased total cholesterol and LDL (p <0.05) compared to normal and negative controls. The highest dose significantly decreased triglyceride levels (p <0.05) and increased HDL levels (p <0.05) compared to normal and negative controls. Based on these results, metformin has a potential effect of antihyperlipidemic at a dose of 225 mg/kg BW rat.

Keywords

Cholesterol, High-Fat Diet, Hyperlipidemic, Metformin, Triglyceride.
User
Subscription Login to verify subscription
Notifications
Font Size

  • Dipiro JT, Wells BG, Schwinghammer TL, Dipiro CV. Pharmacotherapy Handbook (seventh ed). New York: Mc Graw Hill; 2015.

  • World Health Organization. Global Health Observatory (GHO) data Raised cholesterol [internet]. 2019 [cited 2 Feb 2019]. Available from: https://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/.

  • Kemenkes RI. Laporan Nasional Riskesdas 2018. Badan Penelitian dan Pengembangan Kesehatan; 2018.

  • Whalen K, Finkel R, Panavelil TA. Lippincott illustrated reviews : Pharmacology. (R. Finkel & T. A. Panavelil, Eds.) (sixth edit). Philadelphia: Wolters Kluwer Health; 2015.

  • Wulffele MG, Kooy A, Zeeuw DDE, Stehouwer CDA, Gansevoort RT. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: A systematic review. Journal of Internal Medicine. 2004; 256(1):1–14. https://doi.org/10.1111/j.13652796.2004.01328.x. PMid:15189360.

  • Kashi Z, Mahrooz A, Kianmehr A, Alizadeh A. The role of metformin response in lipid metabolism in patients with recent-onset type 2 diabetes: HbA1c level as a criterion for designating patients as responders or nonresponders to metformin. PLOS ONE; 2016. p. 1–10. https://doi.org/10.1371/journal.pone.0151543. PMid:26978661 PMCid:PMC4792461

  • Al-jabouri NHM. Effects of oral hypoglycemic drugs on serum lipid profile in hyperlipidemic rats. 2013; 10(1);245–56.

  • Deepika MY, Devi MARL, Nagaraju B, Deepthi PR, Bakshi BV. Anti obesity activity and beneficial effects of methanolic extract of desmostachya bipinnata in hfd and progesterone induced obesity in rats and mice. International Journal of Pharmaceutical Science and Research. 2016; 7(11):4644–55.

  • Wardani E. Studi Interaksi Farmakodinamika dan Farmakokinetika Simvastatin dengan Ekstrak Daun Kemuning (Murraya paniculata L.) sebagai Antihiperlipidemia [disertasi]. Depok: Universitas Indonesia; 2019.

  • Hasimun P, Sukandar E, Adnyana I, Tjahjono D. A simple method for screening antihyperlipidemic agents. International Journal of Pharmacology. 2011; 7(1):74–8. https://doi.org/10.3923/ijp.2011.74.78.

  • Li S, Jin S, Song C, Chen C, Zhang Y, Xiang Y, Jiang H. The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice. Journal of Ethnopharmacology. 2016; 177:10–18. https://doi.org/10.1016/j.jep.2015.11.017. PMid:26584875.

  • Kusuma AM, Asarina Y, Rahmawati YI, Susanti S. Efek ekstrak bawang dayak (Eleutherine palmifolia (L.)Merr) dan Ubi Ungu (Ipomoea batatas L) terhadap penurunan kadar kolesterol dan trigliserida darah pada tikus jantan. Jurnal Kefarmasian Indonesia. 2017; 6(2):108–16. https://doi.org/10.22435/jki.v6i2.6225.108-116.

  • Duntas LH, Brenta G. A renewed focus on the association between thyroid hormones and lipid metabolism. Frontiers in Endocrinology. 2018; 9(Sep). https://doi.org/10.3389/fendo.2018.00511. PMid:30233497 PMCid:PMC6129606.

  • Malin SK, Kashyap SR. Effects of metformin on weight loss: Potential mechanisms. Current Opinion in Endocrinology and Diabetes and Obesity. 2014; 21(5):323–9. https://doi.org/10.1097/MED.0000000000000095. PMid:25105996.

  • van Stee MF, de Graaf AA, Groen AK. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovascular Diabetology. 2018; 17(1):1-22. https://doi.org/10.1186/s12933-018-0738-4. PMid:29960584 PMCid:PMC6026339.

  • Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017; 60(9):1577–85. https:// doi.org/10.1007/s00125-017-4342-z. PMid:28776086. PMCid:PMC5552828.

  • Lv WS, Wen JP, Li L, Sun RX, Wang J, Xian YX, Gao YY. The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats. Brain Research. 2012; 1444:11–19. https://doi.org/10.1016/j.brainres.2012.01.028. PMid:22325091.


Abstract Views: 307

PDF Views: 0




  • Effects of Metformin on High-Fat Diet-Induced Hyperlipidemic Rats

Abstract Views: 307  |  PDF Views: 0

Authors

Annisa Triskamalia Nurmalinda
Laboratory of Pharmacology and Toxicology, Universitas Indonesia, Kampus UI Depok, 16424, Indonesia
Tri Wahyuni
Laboratory of Pharmacology and Toxicology, Universitas Indonesia, Kampus UI Depok, 16424, Indonesia
Anton Bahtiar
Laboratory of Pharmacology and Toxicology, Universitas Indonesia, Kampus UI Depok, 16424, Indonesia

Abstract


Metformin as insulin sensitizer is now often associated with a significant decrease in plasma triglycerides, plasma total cholesterol, LDL cholesterol, and a significant increase in plasma HDL cholesterol without causing hypoglycemia. Current research aim are to determine the effects of metformin on high-fat diet-induced hyperlipidemic rats. To this end, a total of 30 Sprague-Dawley rats were divided into six groups (N = 5). Normal control was not treated, the negative group was given 0.5% CMC, the positive group used simvastatin dose of 1.8 mg/kg BW/day orally and three variation dose groups of metformin were given at a dose of 225; 450; and 900 mg/kg BW rat/day orally. Induction was carried out for 28 days and continued for 14 days treated with an administration orally. Lipid profile was measured by the colorimetric enzymatic method. As a result, all doses of metformin significantly decreased total cholesterol and LDL (p <0.05) compared to normal and negative controls. The highest dose significantly decreased triglyceride levels (p <0.05) and increased HDL levels (p <0.05) compared to normal and negative controls. Based on these results, metformin has a potential effect of antihyperlipidemic at a dose of 225 mg/kg BW rat.

Keywords


Cholesterol, High-Fat Diet, Hyperlipidemic, Metformin, Triglyceride.

References





DOI: https://doi.org/10.18311/ti%2F2019%2Fv26i1%2F24192